Phreesia, Inc. (NYSE:PHR) Short Interest Update

Phreesia, Inc. (NYSE:PHR) was the target of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 2,730,000 shares, a drop of 14.7% from the November 30th total of 3,200,000 shares. Based on an average daily trading volume, of 406,000 shares, the days-to-cover ratio is currently 6.7 days.

Analysts Set New Price Targets

Several brokerages have weighed in on PHR. Needham & Company LLC restated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research note on Tuesday, December 10th. Robert W. Baird dropped their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 11th. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. DA Davidson reiterated a “buy” rating and issued a $32.00 price objective on shares of Phreesia in a research note on Thursday, September 5th. Finally, JPMorgan Chase & Co. boosted their target price on Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Monday, September 9th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $29.33.

Phreesia Stock Performance

NYSE PHR remained flat at $25.76 during trading on Friday. 242,154 shares of the company’s stock traded hands, compared to its average volume of 448,706. The company has a quick ratio of 1.77, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock has a market capitalization of $1.50 billion, a PE ratio of -17.52 and a beta of 0.98. Phreesia has a 1-year low of $17.07 and a 1-year high of $29.16. The business’s 50-day simple moving average is $21.30 and its 200 day simple moving average is $22.18.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. During the same period in the prior year, the company posted ($0.58) EPS. Phreesia’s revenue was up 16.6% compared to the same quarter last year. On average, analysts expect that Phreesia will post -1.16 EPS for the current year.

Insider Activity at Phreesia

In other Phreesia news, CEO Chaim Indig sold 3,089 shares of the business’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $21.03, for a total transaction of $64,961.67. Following the completion of the sale, the chief executive officer now owns 1,220,647 shares in the company, valued at approximately $25,670,206.41. The trade was a 0.25 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, General Counsel Allison C. Hoffman sold 3,495 shares of Phreesia stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $24.88, for a total transaction of $86,955.60. Following the transaction, the general counsel now owns 116,296 shares of the company’s stock, valued at $2,893,444.48. This represents a 2.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 90,342 shares of company stock worth $2,041,225 in the last quarter. 5.80% of the stock is owned by insiders.

Institutional Trading of Phreesia

A number of hedge funds and other institutional investors have recently made changes to their positions in PHR. Franklin Resources Inc. increased its holdings in Phreesia by 3.0% during the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock worth $31,495,000 after acquiring an additional 42,973 shares during the period. Geode Capital Management LLC grew its position in shares of Phreesia by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after purchasing an additional 55,934 shares in the last quarter. M&T Bank Corp raised its position in shares of Phreesia by 4.6% in the third quarter. M&T Bank Corp now owns 35,127 shares of the company’s stock worth $801,000 after buying an additional 1,535 shares in the last quarter. Barclays PLC raised its position in shares of Phreesia by 83.6% in the third quarter. Barclays PLC now owns 94,929 shares of the company’s stock worth $2,163,000 after buying an additional 43,225 shares in the last quarter. Finally, XTX Topco Ltd bought a new stake in Phreesia during the third quarter valued at $247,000. 92.10% of the stock is currently owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.